{
    "nct_id": "NCT04252300",
    "official_title": "Open Label, Fixed Sequences, One-way Cross-over Study to Determine the Effects of Multiple Doses BAY1817080 (150 mg) on the Pharmacokinetics of a 5 mg Dose Rosuvastatin in Healthy Participants",
    "inclusion_criteria": "* Participant is healthy as determined by the investigator\n* White or Black race\n* Body mass index (BMI) ≥ 18.0 and ≤ 30.0 kg/m² at screening\n* Body weight of at least 50 kg at screening\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 55 Years",
    "exclusion_criteria": "* Known or suspected allergy or hypersensitivity to BAY1817080, rosuvastatin or any of their excipients\n* Asian race\n* Contraindications to rosuvastatin\n* Any use of systemic or topically active medication or herbal remedies, prescription or non-prescription, within 1 week prior to the first study intervention administration or during the study until follow-up (occasional use of ibuprofen is permissible)\n* History of or positive COVID-19 test or contact with COVID-19 positive subject in past 4 weeks",
    "miscellaneous_criteria": ""
}